Neurolite 0.9 mg Kit ; Powder For Solution is a Health Canada–registered radiopharmaceutical drug (DIN 02327848) held by Lantheus Mi Canada Inc, containing Bicisate Dihydrochloride. Health Canada lists its status as Marketed (status date 04 Sep 2018). Nexara Health has matched 3 registrations of Bicisate Dihydrochloride across 1 other regulated market.
Health Canada registration
| DIN | 02327848 |
|---|---|
| Brand name | Neurolite |
| Active ingredient | Bicisate Dihydrochloride |
| Strength | 0.9 mg |
| Dosage form | Kit ; Powder For Solution |
| Route | Intravenous |
| Company | Lantheus Mi Canada Inc |
| Status | Marketed — 04 Sep 2018 |
| Class | Radiopharmaceutical |
| ATC | V09A CENTRAL NERVOUS SYSTEM |
| AHFS | 36:68.00 |
| Regulator record | Health Canada DPD entry · Product monograph |
Bicisate Dihydrochloride registered in other markets
3 registrations of the same molecule in 1 national registry outside Canada. Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| United States | bicisate dihydrochloride | Jubilant HollisterStier LLC | Injection | FDA NDC | ||
| United States | Bicisate Dihydrochloride | Sigma-Aldrich Corporation | Powder | FDA NDC | ||
| United States | Neurolite | Lantheus Medical Imaging, Inc. | Kit | listed | FDA NDC |
See every manufacturer of Bicisate Dihydrochloride worldwide →
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. Because this DIN is marketed in Canada, supply normally comes through the Canadian channel; where the Canadian presentation is short or discontinued, the registrations above show which regulated markets hold an equivalent that can be imported under the Special Access Programme or for clinical comparator use. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Neurolite (DIN 02327848) marketed in Canada?
Yes. Health Canada lists DIN 02327848 as Marketed as of 04 Sep 2018.
Who holds the Canadian licence for this product?
Lantheus Mi Canada Inc is the company of record in the Health Canada Drug Product Database.
Is Bicisate Dihydrochloride registered outside Canada?
Yes — Nexara Health has matched 3 registrations in 1 other market (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 02327848, status date 2018-09-04; national medicine registries: FDA NDC. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 02327848, status date 2018-09-04; national medicine registries: FDA NDC.
Health Canada Drug Product Database (DPD), DIN 02327848, status date 2018-09-04; national medicine registries: FDA NDC. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.